Skip to content

Proscia

Digital pathology software for labs

Raised to date

$35M

of $35M offered across 1 Form D filing

Investors
21
Last filed
Mar 19, 2025

About

Proscia Inc. is an innovative software company specializing in digital and computational pathology solutions designed to modernize and expedite cancer diagnostics and research. By leveraging advanced technologies, Proscia empowers laboratories and medical professionals to enhance their pathology workflows and provide faster, more accurate diagnoses.

Proscia stands out by integrating AI applications into its flagship software, offering uniquely tailored solutions that address the complexities of modern pathology.

Funding

  • EquityFiled Mar 19, 2025Form D
    $35M/ $35M

Product

Concentriq

Pathology Software

Concentriq is Proscia's flagship enterprise pathology platform that facilitates the digitization of pathology workflows. It provides robust features for viewing, managing, analyzing, and sharing digital pathology images, enhancing the efficiency and accuracy of pathology processes.

  • Supports full digitization of clinical pathology workflows
  • Offers AI applications to assist pathologists
  • Provides a scalable platform suitable for various applications

Built for

Diagnostic laboratories, pharmaceutical companies, and academic medical centers

People on file